Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies

Abstract A candidate multigenic SARS-CoV-2 vaccine based on an MVA vector expressing both viral N and S proteins (MVA-S + N) was immunogenic, and induced T-cell responses and binding antibodies to both antigens but in the absence of detectable neutralizing antibodies. Intranasal immunization with th...

Full description

Bibliographic Details
Main Authors: Chaojie Zhong, Hongjie Xia, Awadalkareem Adam, Binbin Wang, Renee L. Hajnik, Yuejin Liang, Grace H. Rafael, Jing Zou, Xiaofang Wang, Jiaren Sun, Lynn Soong, Alan D. T. Barrett, Scott C. Weaver, Pei-Yong Shi, Tian Wang, Haitao Hu
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00405-5
_version_ 1827613503886721024
author Chaojie Zhong
Hongjie Xia
Awadalkareem Adam
Binbin Wang
Renee L. Hajnik
Yuejin Liang
Grace H. Rafael
Jing Zou
Xiaofang Wang
Jiaren Sun
Lynn Soong
Alan D. T. Barrett
Scott C. Weaver
Pei-Yong Shi
Tian Wang
Haitao Hu
author_facet Chaojie Zhong
Hongjie Xia
Awadalkareem Adam
Binbin Wang
Renee L. Hajnik
Yuejin Liang
Grace H. Rafael
Jing Zou
Xiaofang Wang
Jiaren Sun
Lynn Soong
Alan D. T. Barrett
Scott C. Weaver
Pei-Yong Shi
Tian Wang
Haitao Hu
author_sort Chaojie Zhong
collection DOAJ
description Abstract A candidate multigenic SARS-CoV-2 vaccine based on an MVA vector expressing both viral N and S proteins (MVA-S + N) was immunogenic, and induced T-cell responses and binding antibodies to both antigens but in the absence of detectable neutralizing antibodies. Intranasal immunization with the vaccine diminished viral loads and lung inflammation in mice after SARS-CoV-2 challenge, which correlated with the T-cell response induced by the vaccine in the lung, indicating that T-cell immunity is also likely critical for protection against SARS-CoV-2 infection in addition to neutralizing antibodies.
first_indexed 2024-03-09T08:40:41Z
format Article
id doaj.art-378daaf3c6264d6f95e72af6146211c7
institution Directory Open Access Journal
issn 2059-0105
language English
last_indexed 2024-03-09T08:40:41Z
publishDate 2021-11-01
publisher Nature Portfolio
record_format Article
series npj Vaccines
spelling doaj.art-378daaf3c6264d6f95e72af6146211c72023-12-02T16:49:23ZengNature Portfolionpj Vaccines2059-01052021-11-01611710.1038/s41541-021-00405-5Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodiesChaojie Zhong0Hongjie Xia1Awadalkareem Adam2Binbin Wang3Renee L. Hajnik4Yuejin Liang5Grace H. Rafael6Jing Zou7Xiaofang Wang8Jiaren Sun9Lynn Soong10Alan D. T. Barrett11Scott C. Weaver12Pei-Yong Shi13Tian Wang14Haitao Hu15Department of Microbiology and Immunology, University of Texas Medical BranchDepartment of Biochemistry and Molecular Biology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Biochemistry and Molecular Biology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Pathology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Biochemistry and Molecular Biology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchDepartment of Microbiology and Immunology, University of Texas Medical BranchAbstract A candidate multigenic SARS-CoV-2 vaccine based on an MVA vector expressing both viral N and S proteins (MVA-S + N) was immunogenic, and induced T-cell responses and binding antibodies to both antigens but in the absence of detectable neutralizing antibodies. Intranasal immunization with the vaccine diminished viral loads and lung inflammation in mice after SARS-CoV-2 challenge, which correlated with the T-cell response induced by the vaccine in the lung, indicating that T-cell immunity is also likely critical for protection against SARS-CoV-2 infection in addition to neutralizing antibodies.https://doi.org/10.1038/s41541-021-00405-5
spellingShingle Chaojie Zhong
Hongjie Xia
Awadalkareem Adam
Binbin Wang
Renee L. Hajnik
Yuejin Liang
Grace H. Rafael
Jing Zou
Xiaofang Wang
Jiaren Sun
Lynn Soong
Alan D. T. Barrett
Scott C. Weaver
Pei-Yong Shi
Tian Wang
Haitao Hu
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
npj Vaccines
title Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
title_full Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
title_fullStr Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
title_full_unstemmed Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
title_short Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
title_sort mucosal vaccination induces protection against sars cov 2 in the absence of detectable neutralizing antibodies
url https://doi.org/10.1038/s41541-021-00405-5
work_keys_str_mv AT chaojiezhong mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT hongjiexia mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT awadalkareemadam mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT binbinwang mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT reneelhajnik mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT yuejinliang mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT gracehrafael mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT jingzou mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT xiaofangwang mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT jiarensun mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT lynnsoong mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT alandtbarrett mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT scottcweaver mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT peiyongshi mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT tianwang mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies
AT haitaohu mucosalvaccinationinducesprotectionagainstsarscov2intheabsenceofdetectableneutralizingantibodies